ApprovalTrail

Approval · Notice of Compliance 7915 · 2006

IBUPROFEN: Notice of Compliance 7915

Issued May 1, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7915
Date
May 1, 2006
Company
Vita Health Products Inc.Winnipeg, Manitoba, Canada
Product type
Nonprescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Analgesic / antipyretic
Canadian reference product
ADVIL EXTRA STRENGTH CAPLETS (Wyeth Consumer Healthcare Inc.)

Products in this notice

BrandDINStatus today
IBUPROFEN02268760Cancelled Pre Market
EXTRA STRENGTH IBUPROFEN02268779Cancelled Pre Market

Medicinal ingredients